Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
OPERATING ACTIVITIES:
Net income (loss)	$ 526,230	$ (544,114)
Adjustment to reconcile net loss to net cash provided by operating activities:
Net acquisition of FTT	25,000
Derivative liability (gain) loss	(1,545,336)	74,988
Gain on sale of assets	(180,378)
Depreciation	11,869	3,894
Issuance of Series L Preferred Stock for consulting services	250,000
Amortization of debt discounts	692,603	49,863
Changes in operating assets and liabilities:
Accounts receivable	(126,688)
Accrued interest receivable		(13,137)
Loans receivable		847
Accounts payable	54,282	37,131
Accrued interest	94,161	22,573
Accrued director’s compensation	58,333	38,074
Net cash (used) by operating activities	(139,924)	(329,881)
INVESTING ACTIVITIES:
Net cash provided (used) by investing activities
FINANCING ACTIVITIES:
Borrowings from loans payable, related parties, net	186,199
Borrowings from convertible notes payable	45,000
Borrowings from loans payable-officer	5,000	5,387
Proceeds from sale of Series L Preferred Stock	30,000
Net cash provided by financing activities	266,199	5,387
NET (DECREASE) IN CASH AND CASH EQUIVALENTS	126,275	(324,494)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	18,300	324,494
CASH AND CASH EQUIVALENTS, END OF PERIOD	144,575
Supplemental Disclosures of Cash Flow Information:
Taxes paid
Interest paid
Non-cash investing and financing activities:
Accrual for contingent consideration of acquisition of GOe3, LLC	5,764,227
Issuance of common stock for debt and accrued interest		251,098
Issuance of preferred stock for asset purchase	$ 125,000